New ACC/AHA Hypertension Guidelines for 2025: What to Know for Nurse Practitioners
- by
- Oct 01, 2025
- Videos
You may have already heard the news: the updated hypertension guidelines for 2025 have just been released from the ACC/AHA! So, what changed and what does this mean for your NP board exam?
Get all the answers from Caroline Grantham, MSN, APRN, FNP-BC in this new video on the SMNP Reviews YouTube channel! We’ll walk through what’s changed in new hypertension guidelines for 2025, what’s stayed the same, and most importantly, what you actually need to focus on for your certification exam. Let’s break it down so you feel confident and prepared! 💜
Key Changes to the Hypertension Guidelines 2025
The new guidelines are about getting more personal with patient care, acting earlier, and thinking long-term about heart and brain health. For practicing NPs, this means a shift in how we assess risk and recommend treatment.
While we definitely suggest reading the full ACC/AHA hypertension guidelines for 2025 before you start clinical practice, let’s focus on the most important takeaways for now. The biggest updates revolve around risk assessment, lifestyle targets, and medication strategies.
Blood Pressure: No Change Here!
First, some good news! Let’s do a quick knowledge check. Do you remember the blood pressure categories from the 2017 guidelines?
✅ Normal: <120/80 mmHg
📈 Elevated: 120–129/<80 mmHg
🚩 Stage 1 Hypertension: 130–139/80–89 mmHg
⚠️ Stage 2 Hypertension: ≥140/90 mmHg
If you’ve already memorized these, you’re golden! The 2025 guidelines did not change these categories.
The basic treatment approach also holds steady:
⭐ For Stage 1, we start with lifestyle changes and consider medications based on risk.
⭐ For Stage 2, medications are definitely on the table.
ASCVD Risk Score Replaced by PREVENT Calculator
Okay, now for the biggest change: we’re officially saying goodbye to the ASCVD Risk Score in clinical care and welcoming the PREVENT calculator.
As a refresher, the ASCVD score estimated a person’s 10-year risk of a heart attack or stroke. If a patient with Stage 1 hypertension had an ASCVD score of 10% or higher, we’d add medication.
The new PREVENT calculator is a major upgrade. Here’s why:
✅ Broader Age Range: It’s designed for patients aged 30–79.
✅ Comprehensive Risk Prediction: It predicts risk for total cardiovascular disease (CVD), ASCVD, and heart failure—not just heart attack and stroke.
✅ More Detailed Data: It incorporates A1C, albuminuria (a marker of kidney damage), and social determinants of health.
✅ Long-Term View: It provides both 10-year and 30-year risk projections.
💡 Important note for board prep: Certification exams take time to catch up! If you’re taking your boards in 2025 or even 2026, you will likely still see questions based on the ASCVD risk score. So, don’t throw out that knowledge just yet. The switch to PREVENT is for clinical practice, but you’ll still want the old guidelines in your pocket for exam prep.
Stricter Lifestyle Recommendations
The new hypertension guidelines for 2025 are pushing for earlier and more aggressive lifestyle interventions:
🧂 Sodium: The general goal remains less than 2,300 mg/day, but the ideal target is now less than 1,500 mg/day.
🍷 Alcohol: Total avoidance is now considered the optimal choice.
🕐 Timing: If lifestyle changes don’t improve Stage 1 hypertension after 3–6 months, the guidelines recommend considering medication. The thinking here is that early blood pressure control can help prevent long-term cognitive decline and dementia.
Medication Recommendations
The updated guidelines also refine our approach to medications.
💊 Stage 1 Hypertension: As mentioned, if lifestyle modifications aren’t enough after 3–6 months, it’s time to consider starting medication.
💊 Stage 2 Hypertension: For patients with Stage 2 hypertension, especially if their blood pressure is significantly above goal, combination therapy is now officially recommended from the start.
💊 Fixed-Dose Combinations: The guidelines emphasize using fixed-dose combination pills (like lisinopril-hydrochlorothiazide). This approach simplifies the medication regimen and has been shown to improve patient adherence.
2017 vs 2025 ACC/AHA Hypertension Guidelines (Quick Comparison)
| Topic | 2017 ACC/AHA | 2025 ACC/AHA |
|---|---|---|
| BP Categories | Normal, Elevated, Stage 1, Stage 2 | No change |
| Risk Calculator | ASCVD 10-yr risk used to guide meds in Stage 1 (≥ 10% → add meds) | PREVENT replaces ASCVD in clinical care; 10-yr and 30-yr risk; includes HF risk, A1C, albuminuria, SDOH |
| When to Start Meds (Stage 1) | Lifestyle first; add meds if ASCVD ≥ 10% or clinical CVD/DM/CKD | Lifestyle first; transition to meds guided by PREVENT risk and earlier action if not at goal after 3–6 months |
| Initial Therapy (Stage 2) | Often start 1–2 agents; combos reasonable when BP ≥20/10 above goal | Start combination therapy (prefer fixed-dose) for Stage 2, especially if markedly above goal |
| Lifestyle: Sodium | Goal < 2,300 mg/day; lower is better | Keeps < 2,300 mg/day but sets <1,500 mg/day as the ideal target |
| Lifestyle: Alcohol | Limit intake (men ≤ 2/day, women ≤ 1/day) | Total avoidance is optimal |
| Timing of Re-assessment | Reassess after lifestyle trial; interval not always explicit | 3–6 months of lifestyle for Stage 1 before adding meds if not at goal |
| Target-Organ Damage Focus | Recognize CKD, LVH, retinopathy | Broader emphasis: routine albuminuria screening; use ACEi/ARB when indicated for kidney protection |
| Pregnancy-Related HTN | Addressed; avoid ACEi/ARB; use labetalol, nifedipine, methyldopa | Expanded guidance on screening/management and transitions of care |
| Secondary HTN | Evaluate when indicated (e.g., resistant HTN, hypokalemia) | Earlier, clearer triggers for work-up (e.g., primary aldosteronism) |
| Home/Out-of-Office BP | Strongly recommended for diagnosis/titration (HBPM/ABPM) | Continued and reinforced for diagnosis, titration, and adherence. Home BP monitoring has more emphasis |
| Adherence Strategies | Education, simplify regimen; combo pills reasonable | Fixed-dose combinations emphasized to improve adherence and BP control |
Your Path to Success
Navigating new hypertension guidelines for 2025 can feel like a lot, but these updates are designed to help us provide better, more personalized care. For your board exam, the key is to focus on core hypertension principles: know your BP ranges, first-line medications, and the fundamental differences in managing Stage 1 versus Stage 2.
If you are already practicing, it’s time to start familiarizing yourself with the PREVENT calculator and get more proactive with lifestyle support and combination therapy for your high-risk patients.
Feeling like you need more support? You can also find us on Instagram @smnpreviewsofficial for daily tips and practice questions or check out our full board prep courses. 💜 You’ve got this!
And for more NP learning, check out these other videos:
- NP Board Prep: Pediatric Asthma Treatment Guidelines
- Understanding Basic COPD Treatment Guidelines
- NP Board Prep: Pediatric Musculoskeletal Conditions
Search the Blog
Prepping for Primary Care NP Boards?
Join our Primary Care Live Study Group or check out the Self-Paced Courses & Qbank options!
Learn MoreExplore Specialty NP Qbanks & Mock Exams
Practice with board-style questions for your AGACNP, PMHNP, ENP, WHNP, or PNP exams.
Get StartedJoin our Facebook Group!
Get FREE support and encouragement from thousands of FNP/AGPCNP students and our NP support team.
Join the CommunitySign Up for Free Live Classes
Join us for FREE monthly live study sessions covering topics such as antibiotics, diabetes, musculoskeletal conditions, depression & anxiety, and more!
Grab a Spot